FREE delivery to all EXCLUSIVE BOOKS stores nationwide. FREE delivery to your door on all orders over R450. Excludes all international deliveries.

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Larry J. Anderson
    Product form
      FORMAT: Paperback / softback

      R 6,134.00 Price and availability exclusive to website

      YOU COULD EARN 6,134 FUTURE RETAIL DISCOUNTS.
      ESTIMATED DELIVERY: Approx. 20 - 30 Business Days
      BUY NOW PAY LATER
      From R 1,022.33 per month!
      3x monthly payments of R 2,044.66 with
      4x fortnightly payments of R 1,533.50 with
      Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.
      Format: CONTRIBUTORS: Larry J. Anderson EAN: 9783662521557 COUNTRY: Germany PAGES: WEIGHT: 869 g HEIGHT: 235 cm
      PUBLISHED BY: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG DATE PUBLISHED: 2016-08-23 CITY: GENRE: MEDICAL / Infectious Diseases, MEDICAL / Immunology, MEDICAL / Microbiology, MEDICAL / Pediatrics, MEDICAL / Pulmonary & Thoracic Medicine WIDTH: 155 cm SPINE:

      Book Themes:

      Diseases and disorders, Respiratory medicine, Paediatric medicine, Pharmacology, Microbiology (non-medical)

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.
      Format: CONTRIBUTORS: Larry J. Anderson EAN: 9783662521557 COUNTRY: Germany PAGES: WEIGHT: 869 g HEIGHT: 235 cm
      PUBLISHED BY: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG DATE PUBLISHED: 2016-08-23 CITY: GENRE: MEDICAL / Infectious Diseases, MEDICAL / Immunology, MEDICAL / Microbiology, MEDICAL / Pediatrics, MEDICAL / Pulmonary & Thoracic Medicine WIDTH: 155 cm SPINE:

      Book Themes:

      Diseases and disorders, Respiratory medicine, Paediatric medicine, Pharmacology, Microbiology (non-medical)

      Customer Reviews

      Be the first to write a review
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)
      0%
      (0)

      Recently viewed products

      Login

      Forgot your password?

      Don't have an account yet?
      Create account